SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 14, 2002
Dr. Protein.com, Inc.
---------------------
(Exact name of registrant as specified in its charter)
Delaware 000-33487 33-0954381
- -------- --------- ----------
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of Identification No.)
incorporation or
organization)
1102 Buena Vista, San Clemente, California 92672
- ------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (949) 388-3402
--------------
-----------------------------------------------------------
(Former name or former address, if changed since last report)
1
Item 4. Changes in the Registrant's Certifying Public Accountant
On October 14, 2002, the Registrant's Board of Directors, voted to replace its
independent accountant, Quintanilla Accountancy Corporation ("Quintanilla").
Effective as of October 14, 2002, the Registrant's new independent accountant is
Hall & Company, certified public accountants ("Hall & Company"). The Registrant
retained the accounting firm of Hall & Company on October 14, 2002, as the
principal accountants to audit the Registrant's financial statements. The
Registrant authorized Quintanilla to respond fully to any inquiries from Hall &
Company and to make its work papers available to Hall & Company.
The reports of Quintanilla from March 2, 2000, the date of the Registrant's
inception, through October 14, 2002, did not contain any adverse opinion,
disclaimer of opinion, or qualification or modification as to the certainty,
audit scope or accounting principles. During March 2, 2000, the date of the
Registrant's inception, through October 14, 2002, there were no disagreements
between the Registrant and Quintanilla on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, which
disagreement, if not resolved to the satisfaction of the former independent
auditor, would have caused it to make reference to the subject matter of the
disagreement in connection with its report. In addition, during March 2, 2000
through October 14, 2002, there were no "reportable events" within the meaning
of Item 304 of the Securities and Exchange Commission's Regulation S-K.
Hall & Company reviewed the disclosure provided in this Form 8-K prior to its
filing with the Securities and Exchange Commission.
Item 7. Financial Statements and Exhibits
Exhibits
- --------
16.1 Letter from Hall & Company, certified public accountants, to the
Securities and Exchange Commission dated October 14, 2002.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dr. Protein.com, Inc.
October 14, 2002 By: /s/ Michelle Mirrotto
------------------------------------
Michelle Mirrotto, President